.
MergerLinks Header Logo

Announced

Completed

TriRx completed the acquisition of facility in Kansas from Elanco Animal Health.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Private

Friendly

Pharmaceuticals

Single Bidder

United States

Domestic

Completed

animal health

Majority

Acquisition

Biotechnology

Synopsis

Edit

TriRx, a contract development and manufacturing organization, completed the acquisition of facility in Kansas from Elanco Animal Health, a pharmaceutical company. Financial terms were not disclosed. "We are excited to complete the transaction to acquire the Shawnee facility and look forward to continuing to build on the strategic partnership between Elanco, TriRx, the workforce, and the local community in Shawnee, Kansas. TriRx will transition the Elanco Center of Manufacturing Excellence to a Global Center of Excellence serving the pharmaceutical contract development and manufacturing market," Timothy Tyson, TriRx Chairman & CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US